FAM13A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.778800E-01
Normal-vs-Stage2
6.265600E-01
Normal-vs-Stage3
3.962600E-01
Normal-vs-Stage4
7.570400E-01
Stage1-vs-Stage2
8.699000E-01
Stage1-vs-Stage3
2.390400E-01
Stage1-vs-Stage4
7.204400E-01
Stage2-vs-Stage3
1.794190E-02
Stage2-vs-Stage4
7.012800E-01
Stage3-vs-Stage4
2.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.265000E-01
Normal-vs-AfricanAmerican
4.153600E-01
Normal-vs-Asian
7.515400E-01
Caucasian-vs-AfricanAmerican
6.099200E-01
Caucasian-vs-Asian
8.194200E-01
AfricanAmerican-vs-Asian
8.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.210600E-01
Normal-vs-Female
6.897800E-01
Male-vs-Female
6.254600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.099200E-01
Normal-vs-Age(41-60Yrs)
4.693000E-01
Normal-vs-Age(61-80Yrs)
8.744400E-01
Normal-vs-Age(81-100Yrs)
4.617400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.935400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.732000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.752800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.735900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.446500E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.616600E-01
Normal-vs-Daily Drinker
3.148800E-01
Normal-vs-Weekly Drinker
4.678400E-01
Normal-vs-Occasional Drinker
7.622800E-01
Normal-vs-Social Drinker
3.690800E-01
Non Drinker-vs-Daily Drinker
6.397200E-01
Non Drinker-vs-Weekly Drinker
3.923700E-02
Non Drinker-vs-Occasional Drinker
7.006400E-01
Non Drinker-vs-Social Drinker
8.196000E-01
Daily Drinker-vs-Weekly Drinker
1.275190E-01
Daily Drinker-vs-Occasional Drinker
4.891400E-01
Daily Drinker-vs-Social Drinker
7.151200E-01
Weekly Drinker-vs-Occasional Drinker
1.410770E-01
Weekly Drinker-vs-Social Drinker
1.089570E-02
Occasional Drinker-vs-Social Drinker
5.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.113400E-01
Normal-vs-Grade 2
5.602400E-02
Normal-vs-Grade 3
4.238300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.283000E-01
Grade 1-vs-Grade 3
4.618600E-01
Grade 1-vs-Grade 4
4.113400E-01
Grade 2-vs-Grade 3
5.540600E-01
Grade 2-vs-Grade 4
5.602400E-02
Grade 3-vs-Grade 4
4.238300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.094800E-01
Normal-vs-NonDiabetic
7.344200E-01
Diabetic-vs-NonDiabetic
5.042800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.262400E-01
Normal-vs-NoPancreatitis
8.403600E-01
Pancreatitis-vs-NoPancreatitis
3.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.293600E-01
Normal-vs-N1
6.156000E-01
N0-vs-N1
1.313850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.539200E-01
Normal-vs-TP53-NonMutant
3.627400E-01
TP53-Mutant-vs-TP53-NonMutant
6.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
